Replimune Group
REPL
REPL
157 hedge funds and large institutions have $943M invested in Replimune Group in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 66 increasing their positions, 32 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 143 → 157 (+14)
1.55% more ownership
Funds ownership: 101.83% → 103.37% (+1.5%)
2% more call options, than puts
Call options by funds: $536K | Put options by funds: $528K
Holders
157
Holding in Top 10
4
Calls
$536K
Puts
$528K
Top Buyers
| 1 | +$37.6M | |
| 2 | +$18.2M | |
| 3 | +$13.1M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$11.5M |
| 5 |
RI
RTW Investments
New York
|
+$11.3M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$10.8M | |
| 3 | -$7.78M | |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$5.89M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$4.95M |